We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ReadSense, Strand Life Sciences Partner
News

ReadSense, Strand Life Sciences Partner

ReadSense, Strand Life Sciences Partner
News

ReadSense, Strand Life Sciences Partner

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ReadSense, Strand Life Sciences Partner"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Under the arrangement, ReadSense will conduct DNA analysis of blood samples to identify genetic signatures associated with heritable neurological, gastroenterological, and pulmonary disorders. Strand will contribute its software and bioinformatics capabilities for the analysis of the data.

"Our genomic center collaborates with medical institutions on the basis of the request of clinicians themselves, which creates the demand in R&D," ReadSense CEO Vladislav Mileiko said in a statement. "This cooperation with Strand will help us to use the best international practices for solving the wide range of tasks from a selection of personalized genetic tests for the patient to clinical interpretation of whole-genome analysis."

The companies said they anticipate launching the tests in Russia as panels for the most common groups of hereditary diseases "in the near future."

Advertisement